Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing
Journal of Antimicrobial Chemotherapy · 2024
DOI: 10.1093/jac/dkae240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Jianxing Zhou und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Triazoles, Antifungal Agents, Nitriles, Pyridines. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Fujian provincial health technology project.
Abstract (Originalsprache)
Objective
To recommend precision dosing and improve therapeutic efficacy against invasive fungal disease, a physiologically based pharmacokinetic model (PBPK) of oral isavuconazole (ISA) was established and used to explore its disposition across populations in different physiological and pathological states.
Methods
Twenty-five pharmacokinetic (PK) studies of oral ISA were identified through a systematic search of PubMed. Concentration–time data were extracted using WebPlotDigitizer. Physiochemical parameters were obtained from published literature and DrugBank. Model development and simulation used the Simcyp population-based simulator, and visual predictive check and predictive error were used for the model evaluation. Probability of target attainment and the cumulative fraction of response analyses were performed for dose optimization.
Results
The developed PBPK model was successfully validated in different populations. Most predicted concentration–time points aligned with the observed data, with acceptable predictive errors for the critical parameters. We predicted the PK profiles and parameters of ISA in a population with severe hepatic impairment (HI), a population with obesity and paediatric patients aged 1 to less than 6 years old. The probability of target attainment and cumulative fraction of response analyses indicated that the population with severe HI should have half the maintenance dose. The population with obesity and population with severe HI should have a loading dose of 300 mg every 8 h for 2 days. For paediatric patients aged 1 to less than 6 years old, a weight-based dosing regimen (5.38 mg/kg) of ISA was suggested.
Conclusion
The predicted value aligns with observations, suggesting ISA’s potential predictability in PK profiles for other populations. The recommended dosing regimens increase our understanding of the use of ISA in special populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
- Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.
ORCID-Profile: Jianxing Zhou, Xuemei Wu
Förderung
- Fujian provincial health technology project
Zitieren
APA
Zhou, J., Xu, B., Zheng, Y., Huang, H., Wei, Z., Chen, S., Huang, W., Liu, M., Zhang, Y., & Wu, X. (2024). Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae240
Vancouver
Zhou J, Xu B, Zheng Y, Huang H, Wei Z, Chen S, et al. Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae240
BibTeX
@article{Zhou2024,
author = {Zhou, Jianxing and Xu, Baohua and Zheng, You and Huang, Huiping and Wei, Zipeng and Chen, Shengyang and Huang, Wei and Liu, Maobai and Zhang, Yifan and Wu, Xuemei},
title = {Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed precision dosing},
journal = {Journal of Antimicrobial Chemotherapy},
year = {2024},
doi = {10.1093/jac/dkae240}
}
EUVIMED